Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHA:600613)
China · Delayed Price · Currency is CNY 4.730
-0.010 (-0.21%)
Jun 18, 2026, 3:00 PM CST
SHA:600613 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 36.13 | 38.24 | 71.39 | 57 | 48.55 | 69.62 |
Depreciation & Amortization | 86.71 | 86.71 | 91.5 | 93.29 | 96.43 | 66.11 |
Other Amortization | 1.71 | 1.71 | 1.13 | 0.75 | 0.81 | 2.11 |
Loss (Gain) From Sale of Assets | -0.23 | -0.23 | 0.12 | -0.27 | 5.17 | 0 |
Asset Writedown & Restructuring Costs | 0.01 | 0.01 | 1.72 | 55.78 | 2.78 | 27.89 |
Loss (Gain) From Sale of Investments | -3.54 | -3.54 | -1.23 | -1.71 | -1.77 | -28.11 |
Provision & Write-off of Bad Debts | 19.82 | 19.82 | 16.2 | -34.98 | 5.34 | -15.83 |
Other Operating Activities | 99.82 | 28.39 | 28.39 | 20 | 27.03 | -1.8 |
Change in Accounts Receivable | 8.94 | 8.94 | 100.43 | 100.94 | -25.11 | -231.77 |
Change in Inventory | 14.5 | 14.5 | 9.47 | -22.85 | -26.64 | -3.25 |
Change in Accounts Payable | -68.88 | -68.88 | -110.68 | -59.47 | 186.91 | 294.47 |
Operating Cash Flow | 193.79 | 124.47 | 207.79 | 215.59 | 319.23 | 184.26 |
Operating Cash Flow Growth | 42.28% | -40.09% | -3.62% | -32.47% | 73.25% | 85.94% |
Capital Expenditures | -24.34 | -33.22 | -36.39 | -24.51 | -26.64 | -85.96 |
Sale of Property, Plant & Equipment | 0.05 | 0.06 | 0.39 | 4.3 | 0.17 | 0.12 |
Divestitures | - | - | - | - | - | 1.67 |
Investment in Securities | -211.58 | -170 | 0.03 | -20 | 0.3 | -3.11 |
Other Investing Activities | 3.91 | 2.87 | 1.05 | 0.46 | 1.7 | 1.69 |
Investing Cash Flow | -231.96 | -200.29 | -34.92 | -39.75 | -24.47 | -85.58 |
Long-Term Debt Issued | - | 61.88 | 32 | 28.86 | 23.78 | 8.15 |
Total Debt Issued | 76.66 | 61.88 | 32 | 28.86 | 23.78 | 8.15 |
Long-Term Debt Repaid | - | -82.79 | -74.9 | -87.88 | -86.76 | -90.47 |
Total Debt Repaid | -205.86 | -82.79 | -74.9 | -87.88 | -86.76 | -90.47 |
Net Debt Issued (Repaid) | -129.2 | -20.92 | -42.9 | -59.02 | -62.98 | -82.33 |
Common Dividends Paid | -87.62 | -88.22 | -64.18 | -66.29 | -68.97 | -3.97 |
Other Financing Activities | -37.8 | -0.32 | -0.5 | 9.19 | -1.99 | - |
Financing Cash Flow | -254.62 | -109.46 | -107.58 | -116.12 | -133.93 | -86.3 |
Foreign Exchange Rate Adjustments | -0.04 | -0.03 | -0.18 | 0 | 0 | -0 |
Net Cash Flow | -292.84 | -185.3 | 65.1 | 59.72 | 160.82 | 12.39 |
Free Cash Flow | 169.45 | 91.26 | 171.39 | 191.08 | 292.59 | 98.3 |
Free Cash Flow Growth | 89.47% | -46.76% | -10.30% | -34.70% | 197.65% | 3421.80% |
Free Cash Flow Margin | 8.94% | 4.67% | 8.37% | 8.16% | 12.25% | 4.27% |
Free Cash Flow Per Share | 0.29 | 0.17 | 0.31 | 0.37 | 0.54 | 0.18 |
Cash Income Tax Paid | 186.53 | 181.61 | 166.89 | 229.78 | 196.1 | 205.93 |
Levered Free Cash Flow | 144.93 | 77.86 | 180.74 | 127.79 | 235.59 | 2.14 |
Unlevered Free Cash Flow | 151.16 | 84.15 | 188.74 | 137.02 | 246.44 | 7.35 |
Change in Working Capital | -46.64 | -46.64 | -1.42 | 25.72 | 134.88 | 64.28 |